An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...
Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.
A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...
News-Medical.Net on MSN
Breakthrough in FcγRI inhibition opens path to safer autoimmune therapies
An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that ...
A recent study published in Cell Reports demonstrated that vaccine-induced antibody functions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diminish with age. Study: BNT162b2 ...
Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...
A collaboration led by UCLA and the Seattle Children’s Research Institute has yielded new knowledge about the genes responsible for the production and release of immunoglobulin G, the most common type ...
"The hybrid antibody is significantly better than the body's own antibodies at fighting both streptococcus and SARS-CoV-2", say the researchers behind the discovery. Brief facts about the study: basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback